severely active ulcerative colitis (US) and CD (Crohn’s disease) research hub

A Study to Evaluate Mirikizumab Concentrations in Breast Milk Following Administration of Mirikizumab by Subcutaneous Injection in Lactating Participants Receiving Mirikizumab Therapeutically for an Approved Indication

This study looks at how much of the medicine Omvoh (mirikizumab) gets into breast milk when mothers are taking it for conditions like ulcerative colitis or Crohn's disease. The aim is to understand if babies are exposed to the medicine through breastfeeding.